{"corpus_id":14328748,"paper_sha":"edea8a0a2c89d074b7e441a06923f15dfb1aa3cb","doi":"10.1016/j.preteyeres.2012.11.002","arxiv_id":null,"pmid":23219692,"pmcid":"PMC3638089","mag_id":1997402685,"dblp_id":null,"acl_id":null,"title":"Macular telangiectasia type 2.","year":2013,"publication_date":"2013-05-01","venue":"Progress in retinal and eye research","journal":{"name":"Progress in retinal and eye research","pages":"\n          49-77\n        ","volume":"34"},"journal_issn":null,"journal_title":null,"publication_types":["Review","JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't","Review"],"s2_fields_of_study":["Medicine"],"reference_count":206,"citation_count":360,"influential_citation_count":12,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Diagnosis, Differential","mj":false,"ui":"D003937"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Macula Lutea","mj":true,"qs":[{"q":"pathology","mj":false,"ui":"Q000473"},{"q":"physiopathology","mj":false,"ui":"Q000503"}],"ui":"D008266"},{"d":"Retinal Diseases","mj":false,"qs":[{"q":"diagnosis","mj":true,"ui":"Q000175"},{"q":"genetics","mj":false,"ui":"Q000235"},{"q":"pathology","mj":false,"ui":"Q000473"},{"q":"physiopathology","mj":false,"ui":"Q000503"}],"ui":"D012164"},{"d":"Telangiectasis","mj":false,"qs":[{"q":"diagnosis","mj":true,"ui":"Q000175"},{"q":"genetics","mj":false,"ui":"Q000235"},{"q":"pathology","mj":false,"ui":"Q000473"},{"q":"physiopathology","mj":false,"ui":"Q000503"}],"ui":"D013684"},{"d":"Visual Acuity","mj":false,"qs":[{"q":"physiology","mj":false,"ui":"Q000502"}],"ui":"D014792"}],"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Macular telangiectasia type 2 is a bilateral disease of unknown cause with characteristic alterations of the macular capillary network and neurosensory atrophy. Its prevalence may be underestimated and has recently been shown to be as high as 0.1% in persons 40 years and older. Biomicroscopy may show reduced retinal transparency, crystalline deposits, mildly ectatic capillaries, blunted venules, retinal pigment plaques, foveal atrophy, and neovascular complexes. Fluorescein angiography shows telangiectatic capillaries predominantly temporal to the foveola in the early phase and a diffuse hyperfluorescence in the late phase. High-resolution optical coherence tomography (OCT) may reveal disruption of the photoreceptor inner segment-outer segment border, hyporeflective cavities at the level of the inner or outer retina, and atrophy of the retina in later stages. Macular telangiectasia type 2 shows a unique depletion of the macular pigment in the central retina and recent therapeutic trials showed that such depleted areas cannot re-accumulate lutein and zeaxanthin after oral supplementation. There have been various therapeutic approaches with limited or no efficacy. Recent clinical trials with compounds that block vascular endothelial growth factor (VEGF) have established the role of VEGF in the pathophysiology of the disease, but have not shown significant efficacy, at least for the non-neovascular disease stages. Recent progress in structure-function correlation may help to develop surrogate outcome measures for future clinical trials. In this review article, we summarize the current knowledge on macular telangiectasia type 2, including the epidemiology, the genetics, the clinical findings, the staging and the differential diagnosis of the disease. Findings using retinal imaging are discussed, including fluorescein angiography, OCT, adaptive optics imaging, confocal scanning laser ophthalmoscopy, and fundus autofluorescence, as are the findings using visual function testing including visual acuity and fundus-controlled microperimetry. We provide an overview of the therapeutic approaches for both non-neovascular and neovascular disease stages and provide a perspective of future directions including animal models and potential therapeutic approaches.","claims":[{"public_id":"cl_1b2223152939ad99c0e369d6ed16334d","status":"active","text":"Clinical trials with vascular endothelial growth factor-blocking compounds have supported a role for vascular endothelial growth factor in the pathophysiology of macular telangiectasia type 2, but have not shown significant efficacy in non-neovascular disease stages.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_1b2223152939ad99c0e369d6ed16334d"},{"public_id":"cl_7e1b8e530c9e039b96673c963db5bc44","status":"active","text":"Fluorescein angiography shows telangiectatic capillaries predominantly temporal to the foveola in the early phase and diffuse hyperfluorescence in the late phase.","confidence":0.92,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_7e1b8e530c9e039b96673c963db5bc44"},{"public_id":"cl_96f5dc5d30ba72ebec0516807be9a5cb","status":"active","text":"High-resolution optical coherence tomography can reveal photoreceptor inner segment-outer segment border disruption, hyporeflective retinal cavities, and retinal atrophy in later stages.","confidence":0.9,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_96f5dc5d30ba72ebec0516807be9a5cb"},{"public_id":"cl_ad2f4138dae7348f250ac98fdc678e24","status":"active","text":"Macular telangiectasia type 2 shows a unique depletion of macular pigment in the central retina.","confidence":0.93,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_ad2f4138dae7348f250ac98fdc678e24"},{"public_id":"cl_c52836a4f35362fb8fb5ebe939966e70","status":"active","text":"Recent therapeutic trials indicate that depleted macular pigment areas cannot re-accumulate lutein and zeaxanthin after oral supplementation.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_c52836a4f35362fb8fb5ebe939966e70"}],"concepts":[{"public_id":"co_0ea25759229033c0335c5667a2d66770","status":"active","name":"central retina","description":"The central retinal region around the fovea and macula.","types":["anatomical region"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_0ea25759229033c0335c5667a2d66770"},{"public_id":"co_1fda09640117cefc6b8dfe5dd9f21c65","status":"active","name":"vascular endothelial growth factor","description":"A signaling factor involved in blood vessel growth and permeability.","types":["molecule"],"aliases":["VEGF"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_1fda09640117cefc6b8dfe5dd9f21c65"},{"public_id":"co_5ca9a3a498cf82e13626d5bf6ec09427","status":"active","name":"telangiectatic capillaries","description":"Abnormally dilated capillaries observed in the macular region.","types":["vascular abnormality"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5ca9a3a498cf82e13626d5bf6ec09427"},{"public_id":"co_73a75328a20f4f19a99a20315ae7abeb","status":"active","name":"oral supplementation","description":"Administration of a compound by mouth as a treatment or nutritional intervention.","types":["treatment"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_73a75328a20f4f19a99a20315ae7abeb"},{"public_id":"co_74f2a974c5a1f16c1f45573520a0f326","status":"active","name":"high-resolution optical coherence tomography","description":"An imaging technique that provides detailed cross-sectional views of retinal microstructure.","types":["imaging method"],"aliases":["high-resolution OCT","OCT"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_74f2a974c5a1f16c1f45573520a0f326"},{"public_id":"co_7a4d5e36679134ae8defa7a8d351648b","status":"active","name":"diffuse hyperfluorescence","description":"Widespread late-phase increased fluorescence on angiography.","types":["imaging finding"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7a4d5e36679134ae8defa7a8d351648b"},{"public_id":"co_8966c5130a1b919f1863376106731b82","status":"active","name":"macular pigment","description":"Pigment in the central retina composed mainly of lutein and zeaxanthin.","types":["biological feature"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8966c5130a1b919f1863376106731b82"},{"public_id":"co_99c91e7145ba5580f96bd9a1e3fcce11","status":"active","name":"neurosensory atrophy","description":"Loss or degeneration of neurosensory retinal tissue.","types":["pathology"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_99c91e7145ba5580f96bd9a1e3fcce11"},{"public_id":"co_9a5340d9ba5f6bb0c5b94d354c706bd7","status":"active","name":"fluorescein angiography","description":"An ocular angiographic imaging technique using fluorescein dye to visualize retinal circulation.","types":["imaging method"],"aliases":["FA"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_9a5340d9ba5f6bb0c5b94d354c706bd7"},{"public_id":"co_ab98c4645394809972dbb13a174b9a01","status":"active","name":"macular capillary network","description":"The network of capillaries in the macula that is altered in this disease.","types":["anatomical structure"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ab98c4645394809972dbb13a174b9a01"},{"public_id":"co_c388d21f8696cbe4ad62ab6e8490b46a","status":"active","name":"macular telangiectasia type 2","description":"A bilateral macular disease characterized by alterations of the macular capillary network and neurosensory atrophy.","types":["disease"],"aliases":["MacTel type 2","MacTel2"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c388d21f8696cbe4ad62ab6e8490b46a"},{"public_id":"co_ce5473aed0fde933fe2930f9b4be1985","status":"active","name":"non-neovascular disease stages","description":"Stages of disease without neovascular complications.","types":["disease stage"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ce5473aed0fde933fe2930f9b4be1985"},{"public_id":"co_fb1a0f9bd631e763be0ce354ab2df25f","status":"active","name":"photoreceptor inner segment-outer segment border","description":"The retinal layer boundary between photoreceptor inner and outer segments.","types":["anatomical structure"],"aliases":["IS/OS border"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_fb1a0f9bd631e763be0ce354ab2df25f"},{"public_id":"co_fdc92947f264c047e89d40d0da883d16","status":"active","name":"lutein and zeaxanthin","description":"Dietary carotenoids that make up macular pigment and can be given as oral supplements.","types":["compound"],"aliases":["lutein","zeaxanthin"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_fdc92947f264c047e89d40d0da883d16"},{"public_id":"co_fecc1330403ffd057a65b9d5fdb9c0f1","status":"active","name":"hyporeflective cavities","description":"Low-reflectivity cavities seen within the inner or outer retina on optical coherence tomography.","types":["imaging finding"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_fecc1330403ffd057a65b9d5fdb9c0f1"}],"external_ids":{"DOI":"10.1016/j.preteyeres.2012.11.002","ArXiv":null,"PubMed":23219692,"PubMedCentral":"PMC3638089","MAG":1997402685,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/14328748","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631411,"paper_uid":"5da44fbb-4755-4724-bb42-2a2cae94217e","canonical_identity":{"paper_id":631411,"paper_uid":"5da44fbb-4755-4724-bb42-2a2cae94217e","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/14328748"}